I am a Biostatistician that is fascinated by Machine Learning and Deep Learning and their applications in Omics and biological data (Bioinformatics in general). I have Experience in analysis and modeling of large scale genomics and transcriptomics data and also in design and analysis of clinical trials through working in a pharmaceutical company.I am a Biostatistician that is fascinated by Machine Learning and Deep Learning and their applications in Omics and biological data (Bioinformatics in general). I have Experience in analysis and modeling of large scale genomics and transcriptomics data and also in design and analysis of clinical trials through working in a pharmaceutical company.
Pan-cancer integrative analysis of whole-genome De novo somatic point mutations reveals 17 cancer types
Sept. 25, 2019, 9 a.m.
Whole-Genome Analysis of De Novo Somatic Point Mutations Reveals Novel Mutational Biomarkers in Pancreatic Cancer
Jan. 1, 2020, 8 a.m.
DeepDRA: Drug Repurposing using Multi-Omics Data Integration with Autoencoders
T. Mohammadzadeh-Vardin,A. Ghareyazi,A. Gharizadeh,K. AbbasiandH.R. Rabiee
2024
PLOS
HGTDR: Advancing drug repurposing with heterogeneous graph transformers
A. Gharizadeh,K. Abbasi,A. Ghareyazi,M.R. MofradandH.R. Rabiee
2024
Oxford
Pan-cancer integrative analysis of whole-genome De novo somatic point mutations reveals 17 cancer types
A. Ghareyazi,A. Kazemi,K. Hamidieh,H. Dashti,M.S. Tahaei,H.R. Rabiee,H. Alinejad-RoknyandI. Dehzangi
2022
Springer
Whole-Genome Analysis of De Novo Somatic Point Mutations Reveals Novel Mutational Biomarkers in Pancreatic Cancer
A. Ghareyazi,A. Mohseni,H. Dashti,A. Beheshti,A. Dehzangi,H.R. RabieeandH. Alinejad-Rokny